Triangle Biotech /tags/triangle-biotech Triangle Biotech en-US Copyright Mon, 05 Aug 2024 00:55:54 GMT FDA approval for RTP biotech could benefit patients and the region /health/2024-08-04/fda-approval-nc-rtp-durham-biotech-humacyte-atev-research-triangle-research-development NC biotech company Humacyte will receive an FDA decision this week that will determine whether their engineered tissue product can be made available for widespread use. Mon, 05 Aug 2024 00:55:54 GMT /health/2024-08-04/fda-approval-nc-rtp-durham-biotech-humacyte-atev-research-triangle-research-development Lily Burton Record year for life sciences investments in North Carolina /science-technology/2023-01-17/record-year-for-life-sciences-investments-in-north-carolina Companies announced 33 projects this year that will total $2.1 billion of investments and more than 2,700 new jobs in life sciences and related industries, according to a new report. Tue, 17 Jan 2023 21:52:05 GMT /science-technology/2023-01-17/record-year-for-life-sciences-investments-in-north-carolina Jason deBruyn Durham Tech receives $6M donation to expand life sciences program /news/2023-01-11/durham-tech-receives-6m-donation-to-expand-life-sciences-program It’s the largest donation that the college has ever received. Thu, 12 Jan 2023 00:00:14 GMT /news/2023-01-11/durham-tech-receives-6m-donation-to-expand-life-sciences-program Sharryse Piggott With New Public Offering, Triangle Biotech Scene Hopes For A Win /science-technology/2017-05-24/with-new-public-offering-triangle-biotech-scene-hopes-for-a-win It is tough out there for biotech companies. The rewards can be big, but the time frames are long and the risks are high. Research Triangle Park-based G1… Wed, 24 May 2017 16:17:20 GMT /science-technology/2017-05-24/with-new-public-offering-triangle-biotech-scene-hopes-for-a-win Jennifer Brookland , Frank Stasio With New Public Offering, Triangle Biotech Scene Hopes For A Win /show/the-state-of-things/2017-05-24/with-new-public-offering-triangle-biotech-scene-hopes-for-a-win It is tough out there for biotech companies. The rewards can be big, but the time frames are long and the risks are high. Research Triangle Park-based G1… Wed, 24 May 2017 16:17:20 GMT /show/the-state-of-things/2017-05-24/with-new-public-offering-triangle-biotech-scene-hopes-for-a-win Jennifer Brookland , Frank Stasio